Community-acquired pneumonia causes great mortality and morbidity and high costs
worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of …

While the world is grappling with the consequences of a global pandemic related to SARS-
CoV-2 causing severe pneumonia, available evidence points to bacterial infection with …

Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …

Importance In patients with severe community-acquired pneumonia, treatment failure is
associated with excessive inflammatory response and worse outcomes. Corticosteroids may …

Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

Community‐acquired pneumonia (CAP) in adults is an infectious disease with high
morbidity in China and the rest of the world. With the changing pattern in the etiological …

Key Clinical Points Community-Acquired Pneumonia Community-acquired pneumonia
remains a leading cause of death in the United States and around the world. Although the …

Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity
with important clinical impact across the globe. India accounts for 23 per cent of global …

Purpose To evaluate the efficacy of combined vitamin C, hydrocortisone, and thiamine in
patients with severe pneumonia. Materials and methods All consecutive patients with severe …

Die vorliegende Leitlinie umfasst ein neues und aktualisiertes Konzept der Behandlung und
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …